Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024. Which stocks will surge next?Unlock AI-picked Stocks

Reasons to Bet on Cross Country Healthcare (CCRN) Stock

Published 12/30/2021, 10:30 PM
Updated 07/09/2023, 06:31 AM

Cross Country Healthcare (NASDAQ:CCRN), Inc. CCRN is a staffing services provider that has performed brilliantly over the past year and has the potential to sustain the momentum in the near term. Consequently, if you have not taken advantage of the share-price appreciation yet, it’s time you add the stock to your portfolio.

What Makes CCRN an Attractive Pick?

An Outperformer: A glimpse of the company’s price trend reveals that the stock has had an impressive run on the bourse over the past year. Shares of Cross Country Healthcare have returned 212.8%, significantly outperforming the 47% growth of the industry it belongs to.

Solid Rank: Cross Country Healthcare currently carries a Zacks Rank #1 (Strong Buy). Our research shows that stocks with a Zacks Rank #1 or 2 (Buy) offer attractive investment opportunities. Thus, the company is a compelling investment proposition at the moment. You can see the complete list of today’s Zacks #1 Rank stocks here.

Northward Estimate Revisions: The direction of estimate revisions serves as an important pointer when it comes to the price of a stock. Four estimates for 2021 moved north over the past 60 days versus no southward revision, reflecting analysts’ confidence in the stock. Over the same period, the Zacks Consensus Estimate for 2021 earnings has moved 73.6% north.

Positive Earnings Surprise History: Cross Country Healthcare has an impressive earnings surprise history. The company outpaced the Zacks Consensus Estimate in all of the trailing four quarters, delivering an average beat of 75%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Country Healthcare is currently benefiting from the pandemic-induced increase in demand for healthcare staffing, investments in headcount and technology, and an increase in operational effectiveness.

Digital transformation and operational efficiency have been enabling the company to cater to the continuously increasing demand in specialties such as emergency room, operating room, labor, pediatrics, and delivery and medical-surgical services. The recent acquisition of Workforce Solutions Group expands Cross Country Healthcare’s go-to-market strategy and strengthens its foothold in the home care market.

Other Stocks to Consider

Some other stocks in the broader Business Services sector that investors can consider are Avis Budget (NASDAQ:CAR) CAR, sporting a Zacks Rank #1, and Accenture (NYSE:ACN) ACN and Charles River Associates CRAI, each carrying a Zacks Rank #2 (Buy).

Avis Budget has an expected earnings growth rate of 453.5% for the current year. The company has a trailing four-quarter earnings surprise of 76.9%, on average.

Avis Budget’s shares have surged 445.3% in the past year. The company has a long-term earnings growth of 18.8%.

Accenture has an expected earnings growth rate of 19.8% for the current year. The company has a trailing four-quarter earnings surprise of 5.3%, on average.

Accenture’s shares have surged 58.4% in the past year. The company has a long-term earnings growth of 10%.

Charles River Associates has an expected earnings growth rate of 61.2% for the current year. The company has a trailing four-quarter earnings surprise of 51%, on average.

Charles River’s shares have surged 82.6% in the past year. The company has a long-term earnings growth of 15.5%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Top 10 Stocks for 2022

In addition to the investment ideas discussed above, would you like to know about our 10 top picks for the entirety of 2022?

From inception in 2012 through November, the Zacks Top 10 Stocks gained an impressive +962.5% versus the S&P 500’s +329.4%. Now our Director of Research is combing through 4,000 companies covered by the Zacks Rank to handpick the best 10 tickers to buy and hold. Don’t miss your chance to get in on these stocks when they’re released on January 3.

Be First To New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Accenture PLC (ACN): Free Stock Analysis Report

Charles River Associates (CRAI): Free Stock Analysis Report

Avis Budget Group, Inc. (CAR): Free Stock Analysis Report

Cross Country Healthcare, Inc. (CCRN): Free Stock Analysis Report

To read this article on Zacks.com click here.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.